Aduro Clean Technologies is drawing quietly escalating attention from short sellers, with the borrow market tightening sharply even as the stock edges higher — a tension worth watching on a micro-cap TSX name with concentrated insider ownership.
The lending setup is the most active signal this week. Availability has fallen to just 15.7% — meaning only about one share remains available to borrow for every six already lent out — and that figure has dropped nearly 29% in seven days alone. The 52-week low for availability is 0.4%, a reminder of how tight this market can get. Cost to borrow has held in a firm band around 16% for most of the past month, up from roughly 13.5% in early June, confirming that demand for borrows is real and sustained. Short interest itself has nearly doubled since mid-June, rising from around 14,000 shares to over 44,500 now, and is up 74% over the past month. In absolute terms that remains tiny — just 0.14% of free float — but the rate of change is striking for a stock this small.
The ORTEX short score of 51.9 sits right on the fence, ranking in the 22nd percentile among peers on short positioning. The days-to-cover figure from the most recent official FINRA filing is 2.8 days — modest, but not negligible given the thin float. Factor scores tell a similar ambiguous story: the utilization rank sits in the 4th percentile (very tight borrow relative to the universe), the days-to-cover rank is 6th percentile, yet the sector score is a neutral 50. No analyst coverage is available in the data, and the valuation data on file is over a year old, so neither the Street's price target nor formal multiples can be cited with confidence here.
Insider ownership is the most stabilising feature of the setup. Founder and CEO Ofer Vicus holds 27.6% of shares outstanding, and both he and independent director Peter Kampian made open-market purchases at CAD 21.20 on June 23 — just below the current price of CAD 22.80. The CEO also bought in May at CAD 19.89. These are small transactions in dollar terms, but the pattern of consistent buying near current prices from a founder who already controls more than a quarter of the company is a meaningful anchor. CFO Mena Beshay added 28,077 shares as recently as July 3. Net insider buying over the past 90 days totals approximately CAD 146,000 across 9,860 shares — a clear accumulation signal rather than noise.
Recent earnings reactions have been mixed. The April 23 print saw the stock fall less than 0.1% the next day before recovering 17% over the following five sessions. The January release produced a 7.4% one-day gain. With the next event scheduled for August 27, there are seven weeks of positioning dynamics ahead before fundamentals re-enter the conversation.
Correlation-linked peers had a choppy week. IREN added 6% and BMNR gained 4.3%, broadly in line with ACT's 4.1% weekly gain. HOLO and BTCS both fell around 5-6%, illustrating how dispersed performance is across this loosely correlated cohort. The correlations themselves are moderate at best (52% peak), so ACT's story remains driven by its own borrow dynamics and insider activity rather than sector momentum.
The setup to watch into August is whether the rapid tightening of availability continues toward the year's lows, and whether that pressure — combined with a stock trading above recent insider purchase prices — produces any change in the short-selling pace.
See the live data behind this article on ORTEX.
Open ACT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
